Although expects personal brinkmanship in these threads wherein everyone is anonymous, and one can vent
their frustrations in life freely, I have trouble understanding why those without a direct interest in the company
find refuge in this conduct here.
The exception with this company is that many of us - if not most of us - await news of the company for personal
and financial reasons. The financial benefit is reliant on the science, which - as far as I can tell -
has not faltered so far.
Our personal reasons differ. When my daughter was alive I spoke to her a lot about Imogene and their
science to help her see that many were working on a cure. She would cling to any straw of hope. I wrote to Imugene many times in an attempt to get her on a trial. All too late, and hers was a life cut short six months ago.
I know many have lost loves ones to cancer recently like myself, and many came across Imugene in desperation to understand the state of the science, in the vain hope of a remedy. This forum has been at times excellent to read, but not now reading these threads is a bit like puling out the weeds .
I would have thought most who have a personal and genuine interest in this company would not stoop to character slurs or innuendoes, when there
is no point.
And - as a word out there - I understand why those thoughtful posts with scientific and business knowledge - have taken a break or left altogether.
I would implore them to return despite the duress in vultures picking apart your analysis. I think I can speak for many that they are sorely missed.
- Forums
- ASX - By Stock
- IMU
- Why IMU is a multi multi bagger
IMU
imugene limited
Add to My Watchlist
18.2%
!
1.3¢

Why IMU is a multi multi bagger, page-27975
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $97.07M |
Open | High | Low | Value | Volume |
1.2¢ | 1.4¢ | 1.1¢ | $625.7K | 50.56M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 5795292 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 3258567 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 5735292 | 0.012 |
35 | 10497532 | 0.011 |
118 | 35980571 | 0.010 |
37 | 19431668 | 0.009 |
13 | 4220748 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 3078567 | 8 |
0.014 | 10063029 | 39 |
0.015 | 6593187 | 20 |
0.016 | 6224494 | 27 |
0.017 | 7006978 | 10 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online